Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1

BACKGROUND: Neonatal hypoxic-ischemic brain damage, characterized by tissue loss and neurologic dysfunction, is a leading cause of mortality and a devastating disease of the central nervous system. We have previously shown that vitexin has been attributed various medicinal properties and has been de...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wen-di, Min, Jia-wei, Huang, Wen-Xian, Wang, Xin, Peng, Yuan-yuan, Han, Song, Yin, Jun, Liu, Wan-Hong, He, Xiao-Hua, Peng, Bi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011387/
https://www.ncbi.nlm.nih.gov/pubmed/29925377
http://dx.doi.org/10.1186/s12974-018-1221-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011387/
https://www.ncbi.nlm.nih.gov/pubmed/29925377
http://dx.doi.org/10.1186/s12974-018-1221-6

Ejemplares similares